Dynavax (DVAX -43%) gets creamed today, dropping steadily from the open and hitting a new...

|About: Dynavax Technologies Corpor... (DVAX)|By:, SA News Editor

Dynavax (DVAX -43%) gets creamed today, dropping steadily from the open and hitting a new 52-week low after the biopharm company reported that the FDA wants it to collect more saftety information from patients on Heplisav, its investigational adult hepatitis B vaccine.